Literature DB >> 22025492

The effects of colloid solutions on renal proximal tubular cells in vitro.

Winfried Neuhaus1, Martin A Schick, Raphael R Bruno, Bianca Schneiker, Carola Y Förster, Norbert Roewer, Christian Wunder.   

Abstract

Renal failure is a common complication of critically ill patients. Colloids such as hydroxyethyl starch (HES), gelatin, or albumin are regularly used for intravascular volume resuscitation, but there are increasing reports about the nephrotoxic side effects of synthetic colloids in septic patients. Therefore, we investigated the influence of colloids (HES130/0.4 (Voluven®), gelatin (Gelafundin®), human albumin, and the crystalloid Sterofundin® ISO on cell viability of human proximal tubular (HK-2) cells. HK-2 cells were incubated with colloids (0.1%-4%) and with equivalent volumes of the crystalloid solution Sterofundin ISO. After 21 hours, cell viability of HK-2 cells was measured by EZ4U assay (dye XTT). Application of HES130/0.4 decreased cell viability significantly in a concentration-dependent manner (86.80% ± 10.79% by 0.5% HES down to 24.02% ± 4.27% by 4% HES). Human albumin (>1.25%) as well as gelatin (>1%) also showed deleterious effects on HK-2 cells. Interestingly, in lower concentrations, human albumin and the crystalloid solution Sterofundin ISO were cytoprotective in comparison with the NaCl control. In conclusion, synthetic and natural colloids showed a harmful impact on HK-2 cells in higher concentrations without any prior proinflammatory stimulus. HES130/0.4 exhibited the most distinctive harmful impact, whereas the application of crystalloid Sterofundin ISO revealed cytoprotective effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025492     DOI: 10.1213/ANE.0b013e3182367a54

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Clinical use of hydroxyethyl starch and serious adverse effects: Need for awareness amongst the medical fraternity.

Authors:  Sushil Kumar
Journal:  Med J Armed Forces India       Date:  2014-07

2.  HES: time to change my mind?

Authors:  Guenther Frank
Journal:  Intensive Care Med       Date:  2018-03-14       Impact factor: 17.440

3.  Nephrotic Syndrome Complications - New and Old. Part 1.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-03

Review 4.  Kidney function after the intraoperative use of 6% tetrastarches (HES 130/0.4 and 0.42).

Authors:  Hironori Ishihara
Journal:  J Anesth       Date:  2013-10-09       Impact factor: 2.078

5.  Low molecular weight pentastarch is more effective than crystalloid solution in goal-directed fluid management in patients undergoing major gastrointestinal surgery.

Authors:  Yoshifumi Kotake; Mitsue Fukuda; Aya Yamagata; Ririko Iwasaki; Daisuke Toyoda; Nobukazu Sato; Ryoichi Ochiai
Journal:  J Anesth       Date:  2013-09-06       Impact factor: 2.078

6.  Effects of 5% Albumin Plus Saline Versus Saline Alone on Outcomes From Large-Volume Resuscitation in Critically Ill Patients.

Authors:  Hernando Gomez; Priyanka Priyanka; Ayham Bataineh; Christopher M Keener; Gilles Clermont; John A Kellum
Journal:  Crit Care Med       Date:  2021-01-01       Impact factor: 9.296

7.  Phosphodiesterase-4 inhibition with rolipram attenuates hepatocellular injury in hyperinflammation in vivo and in vitro without influencing inflammation and HO-1 expression.

Authors:  Jakob Wollborn; Christian Wunder; Jana Stix; Winfried Neuhaus; Rapahel R Bruno; Wolfgang Baar; Sven Flemming; Norbert Roewer; Nicolas Schlegel; Martin A Schick
Journal:  J Pharmacol Pharmacother       Date:  2015 Jan-Mar

Review 8.  Rational fluid management in today's ICU practice.

Authors:  Karsten Bartels; Robert H Thiele; Tong J Gan
Journal:  Crit Care       Date:  2013-03-12       Impact factor: 9.097

9.  Effects of crystalloids and colloids on liver and intestine microcirculation and function in cecal ligation and puncture induced septic rodents.

Authors:  Martin Alexander Schick; Jobst Tobias Isbary; Tanja Stueber; Juergen Brugger; Jan Stumpner; Nicolas Schlegel; Norbert Roewer; Otto Eichelbroenner; Christian Wunder
Journal:  BMC Gastroenterol       Date:  2012-12-17       Impact factor: 3.067

10.  Balanced Hydroxyethylstarch (HES 130/0.4) Impairs Kidney Function In-Vivo without Inflammation.

Authors:  Martin Alexander Schick; Wolfgang Baar; Raphael Romano Bruno; Jakob Wollborn; Christopher Held; Reinhard Schneider; Sven Flemming; Nicolas Schlegel; Norbert Roewer; Winfried Neuhaus; Christian Wunder
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.